Ashcroft v. Iqbal

Holding that a claim is plausible where a plaintiff's allegations enable the court to draw a "reasonable inference" the defendant is liable

Bell Atl. Corp. v. Twombly

Holding that a complaint's allegations should "contain sufficient factual matter, accepted as true, to 'state a claim to relief that is plausible on its face' "

Ebay Inc. v. Mercexchange, L. L. C.

Holding that traditional four-factor test applies to injunctions against patent infringement

KSR International Co. v. Teleflex Inc.

Holding that, in an obviousness analysis, "[r]igid preventative rules that deny factfinders recourse to common sense, however, are neither necessary under our case law nor consistent with it"

Christianson v. Colt Indus. Operating Corp.

Holding that the appeal belonged before the regional circuit because the claims did not arise under patent law

Holmes Grp., v. Vornado Air Circulation Sys., Inc.

Holding that "`[l]inguistic consistency'" required that the same "arising under" test be applied to the jurisdictional statute for patent claims, 28 U.S.C. § 1338, as is used for the general federal jurisdiction statute, 28 U.S.C. § 1331

Christiansburg Garment Co. v. Equal Emp't Opportunity Comm'n

Holding that for a defendant to recoup attorneys fees under § 706(k) of Title VII, a court must find that the plaintiff litigated his or her claim beyond the point where it became “frivolous, unreasonable, or groundless” or where plaintiff acted in bad faith

Phillips v. AWH Corp.

Holding that "because extrinsic evidence can help educate the court regarding the field of the invention and can help the court determine what a person of ordinary skill in the art would understand claim terms to mean, it is permissible for the district court in its sound discretion to admit and use such evidence"

State Oil Co. v. Khan

Holding that court of appeals was correct to apply Supreme Court precedent despite its "infirmities, its increasingly wobbly, moth-eaten foundations" (alteration in original)

Verizon Comm. v. Law Offices of Trinko

Holding even a monopolist has no duty to cooperate with rivals

Rule 12 - Defenses and Objections: When and How Presented; Motion for Judgment on the Pleadings; Consolidating Motions; Waiving Defenses; Pretrial Hearing

Granting the court discretion to exclude matters outside the pleadings presented to the court in defense of a motion to dismiss

Rule 201 - Judicial Notice of Adjudicative Facts

Holding "[n]ormally, in deciding a motion to dismiss for failure to state a claim, courts must limit their inquiry to the facts stated in the complaint and the documents either attached to or incorporated in the complaint. However, courts may also consider matters of which they may take judicial notice."

Section 271 - Infringement of patent

Holding that testing is a "use"

Section 2 - Monopolizing trade a felony; penalty

In § 2 cases under the Sherman Act, as in § 7 cases under the Clayton Act (Brown Shoe Co. v. United States, 370 U.S. 294, 325) there may be submarkets that are separate economic entities.

Section 282 - Presumption of validity; defenses

Granting a presumption of validity to patents

Section 45 - Unfair methods of competition unlawful; prevention by Commission

Providing court-ordered monetary penalties against anyone who engages in conduct previously identified as prohibited in a final cease and desist order, but only if the violator acted with "actual knowledge that such act or practice is unfair or deceptive"

Section 355 - New drugs

Granting the court discretion to change the date on which an ANDA may be approved if "either party to the action failed to reasonably cooperate in expediting the action"

Section 331 - Prohibited acts

Prohibiting the sale of adulterated foods

Section 4 - Jurisdiction of courts; duty of United States attorneys; procedure

Granting jurisdiction to "prevent and restrain" violations of the Sherman Act to federal district courts

Section 355a - Pediatric studies of drugs

Section 314.53 - Submission of patent information

Referring to "those patents that claim the drug product," and those "patents that claim the drug substance"